Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...

The Elton John AIDS Foundation today announced an ambitious expansion of The Rocket Fund, raising its campaign goal to $200 ...

In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...

Gaps in HIV care, including for Kerry and Cork, must be addressed if the Government is to reach its target of no new ...

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

A new survey launched by Global Black Gay Men Connect is seeking responses from Black gay men and Black trans community ...

Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Lenacapavir, approved by the FDA in June, requires only two shots a year. US insurers don't cover it, but access will soon ...

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

The South Carolina Department of Public Health (DPH) is observing its sixth annual PrEP (pre-exposure prophylaxis) Awareness ...